The Chemours Company (CC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary highlights several negative financial indicators, including a 10% decline in revenue, a 15% drop in net income, and a 12% decrease in adjusted EBITDA. Additionally, the free cash flow and gross margin have declined, and forward-looking statements indicate potential risks. The absence of positive strategic initiatives or operational updates further contributes to a negative sentiment. Given the market cap of $3.4 billion, the stock price is likely to experience a negative movement of -2% to -8% over the next two weeks.
Key Financial Performance
Revenue $1.5 billion, down 10% year-over-year, primarily due to lower demand in the Titanium Technologies segment.
Net Income $150 million, a decrease of 15% year-over-year, driven by increased raw material costs and unfavorable currency exchange rates.
Adjusted EBITDA $300 million, down 12% year-over-year, reflecting lower sales volumes and higher operational costs.
Free Cash Flow $100 million, a decline of 20% year-over-year, attributed to increased capital expenditures and working capital requirements.
Gross Margin 35%, a reduction of 3 percentage points year-over-year, due to higher input costs and pricing pressures.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking Statements: The company's forward-looking statements involve risks and uncertainties as described in Chemours' SEC filings. These statements are not guarantees of future performance and are based on assumptions and expectations of future events that may not be realized, indicating potential risks in strategic execution and market conditions.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Advisors Arun
Ahmed Alembic
Andrews Morgan
CEO Director
CFO Spector
Director Shane
Division EDT
Division McNulty
Division Patrick
Division Peter
Division Rizzo
Division Vincent
EDT name
Fischer Goldman
Hassan Ahmed
Hostetter Senior
Inc Research
Jefferies LLC
Osterland Truist
Patrick Fischer
Peter Osterland
President CEO
Relations President
Research Division
Research Hassan
Rizzo Jefferies
Senior VP
Shane Hostetter
Stanley Research
VP CFO
Vincent Andrews
conference comment
CC Transcript
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
Unknown5-6
The earnings call summary highlights several negative financial indicators, including a 10% decline in revenue, a 15% drop in net income, and a 12% decrease in adjusted EBITDA. Additionally, the free cash flow and gross margin have declined, and forward-looking statements indicate potential risks. The absence of positive strategic initiatives or operational updates further contributes to a negative sentiment. Given the market cap of $3.4 billion, the stock price is likely to experience a negative movement of -2% to -8% over the next two weeks.
The Chemours Company (CC) Q4 2025 Earnings Call Transcript
Unknown2-20
The earnings call summary reflects a negative sentiment due to several factors: expected sequential declines in net sales across segments, muted market conditions, and significant cost impacts. Despite some positive elements like Opteon growth and cost-out efforts, the overall guidance indicates a challenging environment. The Q&A session highlighted concerns about inventory levels, market weakness, and unclear management responses regarding capacity rationalizations and market share gains. Given the company's mid-cap size, these challenges are likely to result in a negative stock price movement in the short term.
The Chemours Company (CC) Q3 2025 Earnings Call Transcript
Unknown11-7
The earnings call summary indicates declining sales and EBITDA across multiple segments, operational disruptions, and financial shortfalls. Although there are some positive aspects like cost reductions and strategic growth plans, the overall sentiment is negative due to weak guidance, operational issues, and market uncertainties. The Q&A section further highlights concerns over demand, tariffs, and inventory issues. Given the company's market cap and the negative aspects outweighing positives, a negative stock price movement is anticipated.
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
Positive8-6
The earnings call summary shows strong financial performance, with significant growth in key segments like TSS and Advanced Materials. The strategic agreement with Navin Fluorine and cost reduction initiatives further enhance the outlook. The Q&A section reveals management's confidence in overcoming operational challenges and achieving long-term growth, despite some uncertainties. The market cap suggests a moderate reaction, leading to a positive forecast of 2% to 8% stock price increase over the next two weeks.
CC Slides
CC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
